Sort
24,827 grants matching “epilepsy”
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$4,948,571Richard C. Mohs · Agenebio, Inc. · R01 · FY2019 · AG
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$4,942,354Richard C. Mohs · Agenebio, Inc. · R01 · FY2020 · AG
The Epilepsy Phenome/ Genome Project (EPGP)
$4,928,610Daniel Lowenstein · University Of California, San Francisco · U01 · FY2009 · NS
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$4,903,985Richard C. Mohs · Agenebio, Inc. · R01 · FY2020 · AG
The Epilepsy Phenome/ Genome Project (EPGP)
$4,880,125Daniel Lowenstein · University Of California, San Francisco · U01 · FY2008 · NS
Human Biochemical Genetics
$4,861,152William Gahl · National Human Genome Research Institute · ZIA · FY2019 · HG
IBIC: Integrated Brain Imaging Center for the University of Washington
$4,784,830Thomas J. Grabowski · University Of Washington · RC4 · FY2010 · NS
PET Radiopharmaceutical Sciences
$4,765,174Victor W Pike · National Institute Of Mental Health · ZIA · FY2023 · MH
Human Biochemical Genetics
$4,714,987William Gahl · National Human Genome Research Institute · ZIA · FY2018 · HG
Environment, Epigenetics, Neurodevelopment & Health of Extremely Preterm Children
$4,627,071T Michael O'Shea · Univ Of North Carolina Chapel Hill · UH3 · FY2022 · OD
Decoding the Multifactorial Etiology of Neural Network Dysfunction in Alzheimer's Disease
$4,626,857Lennart Mucke · J. David Gladstone Institutes · P01 · FY2021 · AG
Decoding the Multifactorial Etiology of Neural Network Dysfunction in Alzheimer's Disease
$4,611,009Lennart Mucke · J. David Gladstone Institutes · P01 · FY2022 · AG
Neural network and immune cell dysfunctions in Alzheimer's disease pathogenesis
$4,538,275Lennart Mucke · J. David Gladstone Institutes · RF1 · FY2019 · AG
Fibrinogen and vascular cognitive impairment: mechanisms, imaging, therapeutics
$4,523,685Katerina Akassoglou · J. David Gladstone Institutes · RF1 · FY2019 · AG
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)
$4,517,043Arthur W Toga · University Of Southern California · U54 · FY2017 · NS
Neural Recording and Simulation Tools to Address the Mesoscale Gap
$4,486,816John P Seymour · University Of Texas Hlth Sci Ctr Houston · RF1 · FY2023 · NS
PET Radiopharmaceutical Sciences
$4,463,105Victor W Pike · National Institute Of Mental Health · ZIA · FY2014 · MH
Environment, Epigenetics, Neurodevelopment & Health of Extremely Preterm Children
$4,460,690T Michael O'Shea · Univ Of North Carolina Chapel Hill · UH3 · FY2019 · OD
PET Radiopharmaceutical Sciences
$4,411,702Victor W Pike · National Institute Of Mental Health · ZIA · FY2025 · MH
Impact of Initial Therapy and Response on Long Term Outcome in Children with CAE
$4,374,323Tracy A Glauser · Cincinnati Childrens Hosp Med Ctr · U01 · FY2011 · NS
PET Radiopharmaceutical Sciences
$4,341,347Victor W Pike · National Institute Of Mental Health · ZIA · FY2013 · MH
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)
$4,282,449Arthur W Toga · University Of Southern California · U54 · FY2018 · NS
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)
$4,251,932Arthur W Toga · University Of Southern California · U54 · FY2020 · NS
The Psychiatric Cell Map Initiative: Connecting Genomics, Subcellular Networks, and Higher Order Phenotypes
$4,247,206Nevan J Krogan · University Of California, San Francisco · U01 · FY2021 · MH
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)
$4,245,953Arthur W Toga · University Of Southern California · U54 · FY2021 · NS